NCT04047745

Brief Summary

The primary purpose of this study is to determine if the postoperative oral narcotics consumption in patients receiving liposomal bupivacaine (LB) interscalene brachial plexus nerve block (ISBPB) is different than the narcotics consumption receiving traditional bupivacaine ISBPB for arthroscopic rotator cuff repair analgesia.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
132

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 5, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 7, 2019

Completed
25 days until next milestone

Study Start

First participant enrolled

September 1, 2019

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2021

Completed
Last Updated

August 7, 2019

Status Verified

August 1, 2019

Enrollment Period

2 years

First QC Date

August 5, 2019

Last Update Submit

August 6, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • opioid consumption

    postsurgical opioid consumption

    surgery through 48 hours post-op

Study Arms (2)

liposomal bupivacaine

ACTIVE COMPARATOR
Drug: Liposomal bupivacaine

ropivacaine

ACTIVE COMPARATOR
Drug: Ropivacaine injection

Interventions

interscalene nerve block administered before surgery using 133 mg liposomal bupivacaine with 10mL 0.5% ropivacaine

liposomal bupivacaine

interscale nerve block administered before surgery using 30mL 0.5% ropivacaine

ropivacaine

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Males and females aged 18 years or older with a full-thickness rotator cuff tear (confirmed on MRI) undergoing arthroscopic rotator cuff repair surgery.
  • Anesthesiologists physical status 1, 2, or 3 and normal preoperative motor (Lovett scale: biceps, wrist, thumb) and sensory function.

You may not qualify if:

  • Revision shoulder surgery
  • History of more than 1 prior surgery performed on the operative shoulder
  • Concomitant severe glenohumeral arthritis
  • Concomitant adhesive capsulitis
  • Worker's compensation claim
  • Pregnancy
  • History of hypersensitivity or idiosyncratic reaction to amide-type local anesthetics
  • History of renal or hepatic failure
  • Chronic neuromuscular deficit affecting the surgical limb.
  • Uncontrolled psychiatric or neurologic disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rothman Orthopaedics at Egg Harbor Township

Egg Harbor, New Jersey, 08234, United States

Location

MeSH Terms

Conditions

Rotator Cuff Injuries

Interventions

Ropivacaine

Condition Hierarchy (Ancestors)

RuptureWounds and InjuriesShoulder InjuriesTendon Injuries

Intervention Hierarchy (Ancestors)

AnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Central Study Contacts

Director of Clinical Trials

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 5, 2019

First Posted

August 7, 2019

Study Start

September 1, 2019

Primary Completion

September 1, 2021

Study Completion

September 1, 2021

Last Updated

August 7, 2019

Record last verified: 2019-08

Data Sharing

IPD Sharing
Will not share

Locations